New Market Report: Orexo AB - Product Pipeline Review - 2013

New Pharmaceuticals market report from Global Markets Direct: "Orexo AB - Product Pipeline Review - 2013"

Logo

Boston, MA -- (ReleaseWire) -- 02/13/2014 --Global Market Direct's pharmaceuticals report, "Orexo AB - Product Pipeline Review - 2013" provides data on the Orexo AB's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Orexo AB's corporate website, SEC filings, investor presentations and featured press releases, both from Orexo AB and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Orexo AB - Brief Orexo AB overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Orexo AB human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Orexo AB with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Orexo AB's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Orexo AB's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Orexo AB in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Orexo AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Orexo AB.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Orexo AB and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review
- Swedish Orphan Biovitrum AB - Product Pipeline Review - 2013
- Oasmia Pharmaceutical AB - Product Pipeline Review - 2013
- Karo Bio AB - Product Pipeline Review - 2013
- Affibody AB - Product Pipeline Review - 2013
- NeuroVive Pharmaceutical AB - Product Pipeline Review - 2013
- Alligator Bioscience AB - Product Pipeline Review - 2013
- Camurus AB - Product Pipeline Review - 2013
- Glucox Biotech AB - Product Pipeline Review - 2013
- Respiratorius AB - Product Pipeline Review - 2013

Media Relations Contact

Bill Thompson
Director of Marketing
800-844-8156
http://www.fastmr.com

View this press release online at: http://rwire.com/458652